Shervin Tabrizi, M.D.

Shervin Tabrizi is a physician-scientist and postdoctoral scholar at the Gerstner Center for Cancer Diagnostics at the Broad Institute of MIT and Harvard, and a radiation oncologist at Massachusetts General Hospital. He is co-advised by Chris Love at the Koch Institute at MIT. His work focuses on developing novel technologies to improve the performance of liquid biopsies for cancer detection, using approaches in protein engineering to create agents that can improve the recovery of cell-free DNA from the body.

He has received an ASCO Young Investigator Award, a Prostate Cancer Foundation Young Investigator Award, an AACR Early Stage Investigator Award, and a BroadIgnite Award in support of this work.

Tabrizi earned his M.D. at Harvard Medical School, where he conducted research with Pardis Sabeti on evolution of human genetic resistance to infectious disease. He completed his internship at Brigham and Women's Hospital and completed his residency training in radiation oncology in the Harvard Radiation Oncology Program, a joint program between Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Boston Children's Hospital.